HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mucosal Vaccination with Heterologous Viral Vectored Vaccine Targeting Subdominant SIV Accessory Antigens Strongly Inhibits Early Viral Replication.

Abstract
Conventional HIV T cell vaccine strategies have not been successful in containing acute peak viremia, nor in providing long-term control. We immunized rhesus macaques intramuscularly and rectally using a heterologous adenovirus vectored SIV vaccine regimen encoding normally weakly immunogenic tat, vif, rev and vpr antigens fused to the MHC class II associated invariant chain. Immunizations induced broad T cell responses in all vaccinees. Following up to 10 repeated low-dose intrarectal challenges, vaccinees suppressed early viral replication (P=0.01) and prevented the peak viremia in 5/6 animals. Despite consistently undetectable viremia in 2 out of 6 vaccinees, all animals showed evidence of infection induced immune responses indicating that infection had taken place. Vaccinees, with and without detectable viremia better preserved their rectal CD4+ T cell population and had reduced immune hyperactivation as measured by naïve T cell depletion, Ki-67 and PD-1 expression on T cells. These results indicate that vaccination towards SIV accessory antigens vaccine can provide a level of acute control of SIV replication with a suggestion of beneficial immunological consequences in infected animals of unknown long-term significance. In conclusion, our studies demonstrate that a vaccine encoding subdominant antigens not normally associated with virus control can exert a significant impact on acute peak viremia.
AuthorsHuanbin Xu, Anne-Marie Andersson, Emeline Ragonnaud, Ditte Boilesen, Anders Tolver, Benjamin Anderschou Holbech Jensen, James L Blanchard, Alfredo Nicosia, Antonella Folgori, Stefano Colloca, Riccardo Cortese, Allan Randrup Thomsen, Jan Pravsgaard Christensen, Ronald S Veazey, Peter Johannes Holst
JournalEBioMedicine (EBioMedicine) Vol. 18 Pg. 204-215 (Apr 2017) ISSN: 2352-3964 [Electronic] Netherlands
PMID28302457 (Publication Type: Journal Article)
CopyrightCopyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Antigens, Heterophile
  • SAIDS Vaccines
Topics
  • Adenoviridae (genetics)
  • Animals
  • Antigens, Heterophile (genetics, immunology, metabolism)
  • CD4-Positive T-Lymphocytes (cytology, immunology)
  • CD8-Positive T-Lymphocytes (cytology, immunology)
  • Genetic Vectors (genetics, immunology, metabolism)
  • HEK293 Cells
  • Humans
  • Macaca mulatta
  • Mice
  • Retroviruses, Simian (physiology)
  • SAIDS Vaccines (immunology)
  • Viremia (immunology, prevention & control)
  • Virus Replication (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: